Ping Xu

1.0k total citations
40 papers, 668 citations indexed

About

Ping Xu is a scholar working on Surgery, Molecular Biology and Immunology. According to data from OpenAlex, Ping Xu has authored 40 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 17 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Ping Xu's work include Pancreatitis Pathology and Treatment (13 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Cancer-related molecular mechanisms research (5 papers). Ping Xu is often cited by papers focused on Pancreatitis Pathology and Treatment (13 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Cancer-related molecular mechanisms research (5 papers). Ping Xu collaborates with scholars based in China, Japan and India. Ping Xu's co-authors include Xiaoxiao Meng, Ping Zhao, Chaomin Wan, Zhengrong Wang, Jing Wang, Xiaoli Lou, Jing Wang, Cheng Chen, Kai Xu and Makoto Taniguchi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cochrane Database of Systematic Reviews.

In The Last Decade

Ping Xu

35 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping Xu China 16 254 235 129 113 100 40 668
Françoise Maupas‐Schwalm France 15 143 0.6× 287 1.2× 66 0.5× 124 1.1× 105 1.1× 22 686
Peggy Robinet United States 13 265 1.0× 315 1.3× 78 0.6× 161 1.4× 186 1.9× 19 735
Yi Ma China 13 149 0.6× 326 1.4× 57 0.4× 217 1.9× 74 0.7× 24 942
Theo JC Van Berkel Netherlands 9 183 0.7× 229 1.0× 94 0.7× 130 1.2× 139 1.4× 10 583
Shengkai Zuo China 16 74 0.3× 279 1.2× 62 0.5× 116 1.0× 75 0.8× 30 613
Ángela Vinué Spain 14 152 0.6× 242 1.0× 45 0.3× 179 1.6× 72 0.7× 24 650
Yoshiki Higashijima Japan 14 113 0.4× 362 1.5× 71 0.6× 50 0.4× 69 0.7× 24 729
Jingti Deng China 16 82 0.3× 434 1.8× 84 0.7× 103 0.9× 157 1.6× 31 767
Tomomi Toyonaga Japan 17 300 1.2× 521 2.2× 108 0.8× 189 1.7× 81 0.8× 24 1.1k
Frederick C. deBeer United States 6 251 1.0× 250 1.1× 66 0.5× 173 1.5× 57 0.6× 7 627

Countries citing papers authored by Ping Xu

Since Specialization
Citations

This map shows the geographic impact of Ping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Xu more than expected).

Fields of papers citing papers by Ping Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Xu. The network helps show where Ping Xu may publish in the future.

Co-authorship network of co-authors of Ping Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Xu. A scholar is included among the top collaborators of Ping Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Xu. Ping Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jun‐Yang, Qingning Wang, Zhiguo Wang, et al.. (2024). Mucus-inspired lubricative antibacterial coating to reduce airway complications in an intubation cynomolgus monkey model. Chinese Chemical Letters. 36(8). 110559–110559.
2.
Xu, Ping, et al.. (2024). Cancer marker TNFRSF1A: From single‑cell heterogeneity of renal cell carcinoma to functional validation. Oncology Letters. 28(3). 425–425. 3 indexed citations
3.
4.
Zhang, Chengfei, Ping Xu, Yongsheng Wang, et al.. (2024). STK39 inhibits antiviral immune response by inhibiting DCAF1-mediated PP2A degradation. Acta Pharmaceutica Sinica B. 15(3). 1535–1551.
5.
Sun, Bo, Ping Xu, Pengfei Kong, Yantian Fang, & Hong Fu. (2023). Gastric adenocarcinoma in Situs inversus totalis: a case study and literature review. Frontiers in Oncology. 13. 1238467–1238467.
6.
Wang, Jing, et al.. (2022). Mesenchymal stem cells regulate M1 polarization of peritoneal macrophages through the CARD9‐NF‐κB signaling pathway in severe acute pancreatitis. Journal of Hepato-Biliary-Pancreatic Sciences. 30(3). 338–350. 6 indexed citations
7.
Fang, Dan, Chengfei Zhang, Ping Xu, et al.. (2021). S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1/2 pathways. Cell Biology and Toxicology. 37(4). 555–571. 39 indexed citations
8.
Xiao, Mo, Chengfei Zhang, Ping Xu, et al.. (2021). KCNN4-mediated Ca2+/MET/AKT axis is promising for targeted therapy of pancreatic ductal adenocarcinoma. Acta Pharmacologica Sinica. 43(3). 735–746. 16 indexed citations
9.
Xu, Ping, et al.. (2020). Tumour suppressive long non‐coding RNA AFDN‐DT inhibits gastric cancer invasion via transcriptional regulation. Journal of Cellular and Molecular Medicine. 24(5). 3157–3166. 7 indexed citations
10.
Zhang, Chengfei, Xiaoming Wang, Dan Fang, et al.. (2020). STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway. Theranostics. 11(5). 2108–2122. 29 indexed citations
11.
Liu, Zhen, Jiahao Liu, Yang Li, et al.. (2020). VPS33B suppresses lung adenocarcinoma metastasis and chemoresistance to cisplatin. Genes & Diseases. 8(3). 307–319. 14 indexed citations
12.
Jin, Xin, Xiaoyuan He, Xiaoli Cao, et al.. (2018). Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice. Haematologica. 103(10). 1627–1634. 48 indexed citations
13.
14.
Xu, Zucai, Tao Xue, Xuefeng Wang, et al.. (2011). Role of Signal Transducer and Activator of Transcription-3 in Up-Regulation of GFAP After Epilepsy. Neurochemical Research. 36(12). 2208–2215. 55 indexed citations
15.
Xu, Ping, et al.. (2010). Pioglitazone: A Promising Therapeutic Tool in Sodium Taurocholate-Induced Severe Acute Pancreatitis. Digestive Diseases and Sciences. 56(4). 1082–1089. 15 indexed citations
16.
Xu, Ping. (2007). Pioglitazone attenuates the severity of sodium taurocholate-induced severe acute pancreatitis. World Journal of Gastroenterology. 13(13). 1983–1983. 18 indexed citations
17.
Xu, Ping. (2005). Angiographic Embolization for the Treatment of Epistaxis. 2 indexed citations
18.
Usuki, Yoshinosuke, Ping Xu, Ken‐ichi Fujita, et al.. (2005). Semi-synthesis and biological evaluation of analogues of UK-2A, a novel antifungal antibiotic from Streptomyces sp. 517-02. Bioorganic & Medicinal Chemistry Letters. 15(8). 2011–2014. 15 indexed citations
19.
Usuki, Yoshinosuke, Kimihiko Goto, Ping Xu, et al.. (2002). UK-2A, B, C and D, Novel Antifungal Antibiotics from Streptomyces sp. 517-02 VI(2). Structure-activity Relationships of UK-2A.. The Journal of Antibiotics. 55(6). 607–610. 12 indexed citations
20.
Shibata, Kozo, et al.. (1995). AKD-2A, B, C and D, New Antibiotics from Streptomyces sp. OCU-42815. Taxonomy, Fermentation, Isolation, Structure Elucidation and Biological Activity.. The Journal of Antibiotics. 48(5). 363–368. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Françoise Maupas‐Schwalm Breakdown of academic impact, for papers by Peggy Robinet Breakdown of academic impact, for papers by Yi Ma Breakdown of academic impact, for papers by Theo JC Van Berkel Breakdown of academic impact, for papers by Shengkai Zuo Breakdown of academic impact, for papers by Ángela Vinué Breakdown of academic impact, for papers by Yoshiki Higashijima Breakdown of academic impact, for papers by Jingti Deng Breakdown of academic impact, for papers by Tomomi Toyonaga Breakdown of academic impact, for papers by Frederick C. deBeer
Rankless by CCL
2026